Generated by AI
NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies for chronic and debilitating conditions, with an emphasis on disorders of the gut-brain interaction. Its current product portfolio centers on IB-Stim, a drug-free, non-surgical device worn behind the ear and designed to deliver percutaneous electrical nerve field stimulation for patients with functional abdominal pain associated with irritable bowel syndrome, functional dyspepsia, and related nausea symptoms. The company serves pediatric and adult patients through healthcare settings such as hospitals and clinics, where its therapies are used to support symptom management in targeted gastrointestinal conditions. NeurAxis also works to commercialize evidence-based devices that address unmet needs in digestive health and related neuromodulation care. Headquartered in Carmel, Indiana, NeurAxis operates as a specialized player in the medical device market with a focus on non-invasive treatment options.
Website11611 North Meridian St
Carmel, IN, 46032
United States
The latest articles about NRXS.
Motley Fool Press Release.
Summary of Sep 16's posts. Generated by AI.
Summary of Oct 24's posts. Generated by AI.
No summary yet.
Summary of Oct 24's posts. Generated by AI.
Investors talking about NRXS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.